Brain tryptophan metabolism in schizophrenia: A post mortem study of metabolites on the serotonin and kynurenine pathways in schizophrenic and control subjects (original) (raw)
References
Aghajanian, G. K., Foote, W. E., Sheard, M. H.: Action of psychotogenic drugs on single mid brain raphe neurones. J. Pharmacol. Exp. Ther. 171, 178–187 (1970) Google Scholar
Ashcroft, G. W., Crawford, T. B. B., Cundall, R. L., Davidson, D. L., Dobson, J., Dow, R. C., Eccleston, D., Loose, R. W., Pullar, I. A.: 5-hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration. Psychol. Med. 3, 326–332 (1973) Google Scholar
Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Sharman, D. F., MacDougall, E. C., Stanton, J. B., Binns, J. K.: 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurologic disease. Lancet II, 1049–1052 (1966) Google Scholar
Bernassi, C. A., Bernassi, P., Allegri, G., Ballarin, P.: Tryptophan metabolism in schizophrenic patients. J. Neurochem. 7, 264–270 (1961) Google Scholar
Beskow, J., Gottfries, C. G., Roos, B. E., Winblad, B.: Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and a control group. Acta Psychiat. Scand. 53, 7–20 (1976) Google Scholar
Birkmayer, W., Danielczyk, W., Neumayer, E., Reiderer, P.: Nucleus Ruber and L-dopa psychosis: biochemical post mortem findings. J. Neural Trans. 35, 93–116 (1974) Google Scholar
Bloxham, D. L., Warren, W. H.: Error in the determination of tryptophan by the method of Denkla and Dewey. A revised procedure. Anal. Biochem. 60, 621–625 (1974) Google Scholar
Bowers, M. B., Jr.: Cerebrospinal fluid 5-hydroxyindoles and behaviour after L-tryptophan and pyridoxine administration to psychiatric patients. Neuropharmacol. 9, 599–604 (1970) Google Scholar
Bowers, M. B. Jr.: Central dopamine turnover in schizophrenic syndromes. Arch. Gen. Psychiatry 31, 50–57 (1974) Google Scholar
Bowers, M. B., Heinger, G. R., Gerbode, F. A.: Cerebrospinal fluid, 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients. Int. J. Neuropharmacol. 8, 255–262 (1969) Google Scholar
Carlsson, A.: Does dopamine play a role in schizophrenia. Psychol. Med. 7, 583–597 (1977) Google Scholar
Cochran, E., Robins, E., Grote, S.: Regional serotonin levels in brain: a comparison of depressive suicides and alcoholic suicides with controls. Biol. Psychiatry 11, 283–294 (1976) Google Scholar
Cross, A. J., Crow, T. J., Killpack, W. S., Longden, A., Owen, F., Riley, G. J.: The activities of brain dopamine-β-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls. Psychopharmacology 59, 117–121 (1978) Google Scholar
Crow, T. J., Deakin, J. F. W., Johnstone, E. C., Longden, A.: Dopamine and schizophrenia. Lancet II, 563–566 (1976) Google Scholar
Curzon, G., Green, A. R.: Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindole acetic acid in small regions of rat brain. Br. J. Pharmacol. 39, 653–655 (1970) Google Scholar
Curzon, G., Kantamaneni, B. D.: Transmitters and related substances in brain material: an index of terminal and/or post mortem biochemical change. Lancet I, 156–157 (1978) Google Scholar
Curzon, G., Kantamaneni, B. D., Bartlett, J. R., Bridges, P. K.: Transmitter precursors and metabolites in human ventricular cerebrospinal fluid. J. Neurochem. 26, 613–615 (1976) Google Scholar
De Armond, S. J., Fusco, M. M., Dewey, M. M.: Structure of the human brain, a photographic atlas. New York: O. U. P. 1974 Google Scholar
Denckla, W. D., Dewey, H. K.: The determination of tryptophan in plasma, liver and urine. J. Lab. Clin. Med. 69, 160–169 (1967) Google Scholar
Domino, E. F., Krause, R. R.: Free and bound serum tryptophan in drug free normal controls and chronic schizophrenic patients. Biol. Psychiatry 8, 265–279 (1974) Google Scholar
Faurbye, A., Pind, K.: Investigations on the tryptophan metabolism (via kynurenine) in schizophrenic pateints. Acta Psychiatr. Scand. 40, 244–248 (1964) Google Scholar
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G., Munoz, R.: Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiatry 26, 57–63 (1972) Google Scholar
Gaddum, J. H.: Drugs antagonistic to 5-hydroxytryptamine in Ciba Foundation symposium on hypertension. G. W. Wolstenholme, ed., pp. 75–77. Boston: Little, Brown 1954 Google Scholar
Gal, E. M.: Cerebral tryptophan-2,3-dioxygenase (pyrrolase) and its induction in rat brain. J. Neurochem. 22, 861–863 (1974) Google Scholar
Gillin, J. C., Kaplan, J. A., Wyatt, R. J.: Clinical effects of tryptophan in chronic schizophrenia. Biol. Psychiatry 11, 635–639 (1976) Google Scholar
Goodwin, F. K., Post, R. M.: Studies of amine metabolites in affective illness and in chizophrenia: a comparative analysis. In: Biology of the major psychoses, D. X. Freedman, ed., vol. 54. Res. Publ. Assoc. Res. Nerv. Ment. Dis. New York: Raven Press 1975 Google Scholar
Gottfries, C. G., Roos, B. E., Winblad, B.: Determination of 5-hydroxytryptamine, 5-hydroxyindole acetic acid and homovanillic acid in brain tissue from an autopsy material. Acta Psychiatr. Scand. 50, 496–507 (1974) Google Scholar
Hayaishi, O.: Properties and function of indoleamine-2,3-dioxygenase. J. Biochem. 79, 13P-21P (1976) Google Scholar
Hornykiewicz, O.: Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders. J. Psychiatr. Res. 11, 249–253 (1974) Google Scholar
Joseph, M. H.: The determination of kynurenine; a simple gas-liquid chromatographic method applicable to urine, plasma, brain and CSF. J. Chromatogr. (Biomed. App.) 146, 33–41 (1978) Google Scholar
Joseph, M. H., Baker, H. F.: The determination of 5-hydroxytryptophan and its metabolites in plasma following administration to man. Clin. Chim. Acta 72, 125–131 (1976) Google Scholar
Joseph, M. H., Baker, H. F., Lowson, A. M.: Positive identification of kynurenine in rat and human brain. Biochem. Soc. Trans. 6, 123–126 (1978) Google Scholar
Joseph, M. H., Young, S. N., Curzon, G.: The metabolism of a tryptophan load in rat brain and liver. The influence of hydrocortisone and allopurinol. Biochem. Pharmacol. 25, 2599–2604 (1976) Google Scholar
Leysen, J. E., Niemegeers, C. J. E., Tollenaere, J. P., Laduron, P. M.: Serotonergic component of neuroleptic receptors. Nature 272, 168–171 (1978) Google Scholar
Lloyd, K. G., Farley, I. J., Deck, J. H. N., Hornykiewicz, O.: Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brain stem of suicide victims and control patients. Adv. Biochem. Psychopharmacol. 11, 387–397 (1974) Google Scholar
Manowitz, P., Gilmour, D. G., Raceuskis, J.: Low plasma tryptophan levels in recently hospitalised schizophrenics. Biol. Psychiatry 6, 109–118 (1973) Google Scholar
Payne, I. R., Walsh, E. M., Whittenberg, E. J. R.: Relationship of dietary tryptophan and niacin to tryptophan metabolism in schizophrenics and non-schizophrenics. Am. J. Clin. Nutr. 27, 565–571 (1974) Google Scholar
Pollin, W., Cardin, P. V., Kety, S. S.: Effects of amino acid feedings in schizophrenic patients treated with iproniazid. Science 133, 104–105 (1961) Google Scholar
Post, R. M., Fink, E., Carpenter, W. T., Goodwin, F. K.: Cerebrospinal fluid amine metabolites in acute schizophrenia. Arch. Gen. Psychiatry 32, 1063–1069 (1975) Google Scholar
Praag, H. M. van: Indoleamines in depression. In: Neuroregulators and psychiatric disorders, E. Usdin, D. A. Hamburg, and J. D. Barchas, eds., pp. 163–176. New York: O. U. P. 1977 Google Scholar
Wing, J. K., Cooper, J. E., Sartorius, N.: The description and classification of psychiatric symptoms. An instruction manual for the PSE and Catego system. London: O. U. P. 1974 Google Scholar
Wode-Helgodt, B., Fyrö, B., Gullberg, B., Sedvall, G.: Effect of chlorpromazine treatment on monoamine metabolite levels in CSF of psychotic patients. Acta Psychiatr. Scand. 56, 129–142 (1977) Google Scholar
Woolley, D. W., Shaw, E.: A biochemical and pharmacological suggestion about certain mental disorders. Proc. Natl. Acad. Sci. U.S.A. 40, 228–231 (1954) Google Scholar
Wyatt, R. J., Vaughan, T., Galanter, M., Kaplan, J., Green, R.: Behavioural changes of chronic schizophrenic patients given L-5-hydroxytryptophan. Science 177, 1124–1126 (1972) Google Scholar
Young, S. N., Tsang, D., Lal, S., Sourkes, T. L.: Changes in the tryptophan content of exercised human cerebral cortex. J. Neurochem. 28, 439–440 (1977) Google Scholar